Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIML-NK Cells for Relapsed & Refractory Neuroblastoma
NCT07635056Phase 2Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Dec 2026
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
A Phase 2 trial of cytokine-induced memory-like natural killer cells in neuroblastoma, sponsored by Cincinnati Children's Hospital Medical Center. Planned start Dec 2026; status: recruiting.
02
Drugs
cytokine-induced memory-like natural killer cells
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT07635056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635056.